| Teague Dombeck, MD | |
|
201 E Nicollet Blvd, Fairview Ridges Hospital, Burnsville, MN 55337-5714 | |
| (952) 892-2021 | |
| (952) 892-2670 |
| Full Name | Teague Dombeck |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 22 Years |
| Location | 201 E Nicollet Blvd, Burnsville, Minnesota |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1407815558 | NPI | - | NPPES |
| 47497 | Other | MN | MEDICAL LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 47497 (Minnesota) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Buffalo Hospital | Buffalo, MN | Hospital |
| Sanford Medical Center Thief River Falls | Thief river falls, MN | Hospital |
| Alomere Health | Alexandria, MN | Hospital |
| Centracare Health - Monticello | Monticello, MN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Douglas County Hospital | 0648171413 | 101 |
News Archive
Pfizer Inc. today announced that the United States Food and Drug Administration has approved NIVESTYM (filgrastim-aafi), a biosimilar to Neupogen (filgrastim), for all eligible indications of the reference product.
Age-related macular degeneration (AMD) and its associated vision loss may be connected to the quality of carbohydrates an individual consumes.
Meridian Health Plan was named a 2013 CIO 100 award recipient by IDG's CIO magazine. This annual award program recognizes organizations around the world that exemplify the highest level of operational and strategic excellence in information technology.
The most recent edition of the authoritative Tobacco Atlas, released by the American Cancer Society and World Lung Foundation, ranks nations on their success in combating illegal sales of cigarettes and tobacco products.
Breast cancer patients who possess one of the so-called "breast cancer" or BRCA genetic mutations do not have a higher risk of dying than patients with no BRCA mutations, according to a detailed study by researchers at the Technion-Israel Institute of Technology and the University of Toronto.
› Verified 1 days ago
| Entity Name | Emergency Physicians Professional Association |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801871934 PECOS PAC ID: 9537072657 Enrollment ID: O20031106000068 |
News Archive
Pfizer Inc. today announced that the United States Food and Drug Administration has approved NIVESTYM (filgrastim-aafi), a biosimilar to Neupogen (filgrastim), for all eligible indications of the reference product.
Age-related macular degeneration (AMD) and its associated vision loss may be connected to the quality of carbohydrates an individual consumes.
Meridian Health Plan was named a 2013 CIO 100 award recipient by IDG's CIO magazine. This annual award program recognizes organizations around the world that exemplify the highest level of operational and strategic excellence in information technology.
The most recent edition of the authoritative Tobacco Atlas, released by the American Cancer Society and World Lung Foundation, ranks nations on their success in combating illegal sales of cigarettes and tobacco products.
Breast cancer patients who possess one of the so-called "breast cancer" or BRCA genetic mutations do not have a higher risk of dying than patients with no BRCA mutations, according to a detailed study by researchers at the Technion-Israel Institute of Technology and the University of Toronto.
› Verified 1 days ago
| Entity Name | St. Joseph's Area Health Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023086055 PECOS PAC ID: 0345146510 Enrollment ID: O20031209000521 |
News Archive
Pfizer Inc. today announced that the United States Food and Drug Administration has approved NIVESTYM (filgrastim-aafi), a biosimilar to Neupogen (filgrastim), for all eligible indications of the reference product.
Age-related macular degeneration (AMD) and its associated vision loss may be connected to the quality of carbohydrates an individual consumes.
Meridian Health Plan was named a 2013 CIO 100 award recipient by IDG's CIO magazine. This annual award program recognizes organizations around the world that exemplify the highest level of operational and strategic excellence in information technology.
The most recent edition of the authoritative Tobacco Atlas, released by the American Cancer Society and World Lung Foundation, ranks nations on their success in combating illegal sales of cigarettes and tobacco products.
Breast cancer patients who possess one of the so-called "breast cancer" or BRCA genetic mutations do not have a higher risk of dying than patients with no BRCA mutations, according to a detailed study by researchers at the Technion-Israel Institute of Technology and the University of Toronto.
› Verified 1 days ago
| Entity Name | Douglas County Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1164424305 PECOS PAC ID: 0648171413 Enrollment ID: O20040115000387 |
News Archive
Pfizer Inc. today announced that the United States Food and Drug Administration has approved NIVESTYM (filgrastim-aafi), a biosimilar to Neupogen (filgrastim), for all eligible indications of the reference product.
Age-related macular degeneration (AMD) and its associated vision loss may be connected to the quality of carbohydrates an individual consumes.
Meridian Health Plan was named a 2013 CIO 100 award recipient by IDG's CIO magazine. This annual award program recognizes organizations around the world that exemplify the highest level of operational and strategic excellence in information technology.
The most recent edition of the authoritative Tobacco Atlas, released by the American Cancer Society and World Lung Foundation, ranks nations on their success in combating illegal sales of cigarettes and tobacco products.
Breast cancer patients who possess one of the so-called "breast cancer" or BRCA genetic mutations do not have a higher risk of dying than patients with no BRCA mutations, according to a detailed study by researchers at the Technion-Israel Institute of Technology and the University of Toronto.
› Verified 1 days ago
| Entity Name | Lifecare Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609861095 PECOS PAC ID: 4789586884 Enrollment ID: O20040121000061 |
News Archive
Pfizer Inc. today announced that the United States Food and Drug Administration has approved NIVESTYM (filgrastim-aafi), a biosimilar to Neupogen (filgrastim), for all eligible indications of the reference product.
Age-related macular degeneration (AMD) and its associated vision loss may be connected to the quality of carbohydrates an individual consumes.
Meridian Health Plan was named a 2013 CIO 100 award recipient by IDG's CIO magazine. This annual award program recognizes organizations around the world that exemplify the highest level of operational and strategic excellence in information technology.
The most recent edition of the authoritative Tobacco Atlas, released by the American Cancer Society and World Lung Foundation, ranks nations on their success in combating illegal sales of cigarettes and tobacco products.
Breast cancer patients who possess one of the so-called "breast cancer" or BRCA genetic mutations do not have a higher risk of dying than patients with no BRCA mutations, according to a detailed study by researchers at the Technion-Israel Institute of Technology and the University of Toronto.
› Verified 1 days ago
| Entity Name | St. Joseph's Area Health Services |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1023086055 PECOS PAC ID: 0345146510 Enrollment ID: O20061104000649 |
News Archive
Pfizer Inc. today announced that the United States Food and Drug Administration has approved NIVESTYM (filgrastim-aafi), a biosimilar to Neupogen (filgrastim), for all eligible indications of the reference product.
Age-related macular degeneration (AMD) and its associated vision loss may be connected to the quality of carbohydrates an individual consumes.
Meridian Health Plan was named a 2013 CIO 100 award recipient by IDG's CIO magazine. This annual award program recognizes organizations around the world that exemplify the highest level of operational and strategic excellence in information technology.
The most recent edition of the authoritative Tobacco Atlas, released by the American Cancer Society and World Lung Foundation, ranks nations on their success in combating illegal sales of cigarettes and tobacco products.
Breast cancer patients who possess one of the so-called "breast cancer" or BRCA genetic mutations do not have a higher risk of dying than patients with no BRCA mutations, according to a detailed study by researchers at the Technion-Israel Institute of Technology and the University of Toronto.
› Verified 1 days ago
| Entity Name | Centracare Health System-nr Llc |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1275872772 PECOS PAC ID: 3870739410 Enrollment ID: O20130426000215 |
News Archive
Pfizer Inc. today announced that the United States Food and Drug Administration has approved NIVESTYM (filgrastim-aafi), a biosimilar to Neupogen (filgrastim), for all eligible indications of the reference product.
Age-related macular degeneration (AMD) and its associated vision loss may be connected to the quality of carbohydrates an individual consumes.
Meridian Health Plan was named a 2013 CIO 100 award recipient by IDG's CIO magazine. This annual award program recognizes organizations around the world that exemplify the highest level of operational and strategic excellence in information technology.
The most recent edition of the authoritative Tobacco Atlas, released by the American Cancer Society and World Lung Foundation, ranks nations on their success in combating illegal sales of cigarettes and tobacco products.
Breast cancer patients who possess one of the so-called "breast cancer" or BRCA genetic mutations do not have a higher risk of dying than patients with no BRCA mutations, according to a detailed study by researchers at the Technion-Israel Institute of Technology and the University of Toronto.
› Verified 1 days ago
| Entity Name | Centracare Health System-nr Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558600874 PECOS PAC ID: 3870739410 Enrollment ID: O20130515000683 |
News Archive
Pfizer Inc. today announced that the United States Food and Drug Administration has approved NIVESTYM (filgrastim-aafi), a biosimilar to Neupogen (filgrastim), for all eligible indications of the reference product.
Age-related macular degeneration (AMD) and its associated vision loss may be connected to the quality of carbohydrates an individual consumes.
Meridian Health Plan was named a 2013 CIO 100 award recipient by IDG's CIO magazine. This annual award program recognizes organizations around the world that exemplify the highest level of operational and strategic excellence in information technology.
The most recent edition of the authoritative Tobacco Atlas, released by the American Cancer Society and World Lung Foundation, ranks nations on their success in combating illegal sales of cigarettes and tobacco products.
Breast cancer patients who possess one of the so-called "breast cancer" or BRCA genetic mutations do not have a higher risk of dying than patients with no BRCA mutations, according to a detailed study by researchers at the Technion-Israel Institute of Technology and the University of Toronto.
› Verified 1 days ago
| Entity Name | Sanford Health Network North |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1386047355 PECOS PAC ID: 8022206663 Enrollment ID: O20180205002429 |
News Archive
Pfizer Inc. today announced that the United States Food and Drug Administration has approved NIVESTYM (filgrastim-aafi), a biosimilar to Neupogen (filgrastim), for all eligible indications of the reference product.
Age-related macular degeneration (AMD) and its associated vision loss may be connected to the quality of carbohydrates an individual consumes.
Meridian Health Plan was named a 2013 CIO 100 award recipient by IDG's CIO magazine. This annual award program recognizes organizations around the world that exemplify the highest level of operational and strategic excellence in information technology.
The most recent edition of the authoritative Tobacco Atlas, released by the American Cancer Society and World Lung Foundation, ranks nations on their success in combating illegal sales of cigarettes and tobacco products.
Breast cancer patients who possess one of the so-called "breast cancer" or BRCA genetic mutations do not have a higher risk of dying than patients with no BRCA mutations, according to a detailed study by researchers at the Technion-Israel Institute of Technology and the University of Toronto.
› Verified 1 days ago
| Entity Name | Carris Health - Redwood Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1265914048 PECOS PAC ID: 7911259619 Enrollment ID: O20181129001082 |
News Archive
Pfizer Inc. today announced that the United States Food and Drug Administration has approved NIVESTYM (filgrastim-aafi), a biosimilar to Neupogen (filgrastim), for all eligible indications of the reference product.
Age-related macular degeneration (AMD) and its associated vision loss may be connected to the quality of carbohydrates an individual consumes.
Meridian Health Plan was named a 2013 CIO 100 award recipient by IDG's CIO magazine. This annual award program recognizes organizations around the world that exemplify the highest level of operational and strategic excellence in information technology.
The most recent edition of the authoritative Tobacco Atlas, released by the American Cancer Society and World Lung Foundation, ranks nations on their success in combating illegal sales of cigarettes and tobacco products.
Breast cancer patients who possess one of the so-called "breast cancer" or BRCA genetic mutations do not have a higher risk of dying than patients with no BRCA mutations, according to a detailed study by researchers at the Technion-Israel Institute of Technology and the University of Toronto.
› Verified 1 days ago
| Entity Name | Healthpartners Rc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649470782 PECOS PAC ID: 5890126726 Enrollment ID: O20200618000378 |
News Archive
Pfizer Inc. today announced that the United States Food and Drug Administration has approved NIVESTYM (filgrastim-aafi), a biosimilar to Neupogen (filgrastim), for all eligible indications of the reference product.
Age-related macular degeneration (AMD) and its associated vision loss may be connected to the quality of carbohydrates an individual consumes.
Meridian Health Plan was named a 2013 CIO 100 award recipient by IDG's CIO magazine. This annual award program recognizes organizations around the world that exemplify the highest level of operational and strategic excellence in information technology.
The most recent edition of the authoritative Tobacco Atlas, released by the American Cancer Society and World Lung Foundation, ranks nations on their success in combating illegal sales of cigarettes and tobacco products.
Breast cancer patients who possess one of the so-called "breast cancer" or BRCA genetic mutations do not have a higher risk of dying than patients with no BRCA mutations, according to a detailed study by researchers at the Technion-Israel Institute of Technology and the University of Toronto.
› Verified 1 days ago
| Entity Name | Welia Health |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528031390 PECOS PAC ID: 6709295496 Enrollment ID: O20220125001227 |
News Archive
Pfizer Inc. today announced that the United States Food and Drug Administration has approved NIVESTYM (filgrastim-aafi), a biosimilar to Neupogen (filgrastim), for all eligible indications of the reference product.
Age-related macular degeneration (AMD) and its associated vision loss may be connected to the quality of carbohydrates an individual consumes.
Meridian Health Plan was named a 2013 CIO 100 award recipient by IDG's CIO magazine. This annual award program recognizes organizations around the world that exemplify the highest level of operational and strategic excellence in information technology.
The most recent edition of the authoritative Tobacco Atlas, released by the American Cancer Society and World Lung Foundation, ranks nations on their success in combating illegal sales of cigarettes and tobacco products.
Breast cancer patients who possess one of the so-called "breast cancer" or BRCA genetic mutations do not have a higher risk of dying than patients with no BRCA mutations, according to a detailed study by researchers at the Technion-Israel Institute of Technology and the University of Toronto.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Teague Dombeck, MD 7301 Ohms Lane, Suite 650, Edina, MN 55439 Ph: (952) 835-9880 | Teague Dombeck, MD 201 E Nicollet Blvd, Fairview Ridges Hospital, Burnsville, MN 55337-5714 Ph: (952) 892-2021 |
News Archive
Pfizer Inc. today announced that the United States Food and Drug Administration has approved NIVESTYM (filgrastim-aafi), a biosimilar to Neupogen (filgrastim), for all eligible indications of the reference product.
Age-related macular degeneration (AMD) and its associated vision loss may be connected to the quality of carbohydrates an individual consumes.
Meridian Health Plan was named a 2013 CIO 100 award recipient by IDG's CIO magazine. This annual award program recognizes organizations around the world that exemplify the highest level of operational and strategic excellence in information technology.
The most recent edition of the authoritative Tobacco Atlas, released by the American Cancer Society and World Lung Foundation, ranks nations on their success in combating illegal sales of cigarettes and tobacco products.
Breast cancer patients who possess one of the so-called "breast cancer" or BRCA genetic mutations do not have a higher risk of dying than patients with no BRCA mutations, according to a detailed study by researchers at the Technion-Israel Institute of Technology and the University of Toronto.
› Verified 1 days ago
Viorel Guter, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 14000 Nicollet Ave Ste 100, Burnsville, MN 55337 Phone: 952-428-0200 | |
Thomas Egger Sr., MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 201 E Nicollet Blvd, Fairview Ridges Hospital, Burnsville, MN 55337 Phone: 952-892-2021 Fax: 952-892-2670 | |
Brian Goodman, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 201 E Nicollet Blvd, Fairview Ridges Hospital, Burnsville, MN 55337 Phone: 952-892-2021 Fax: 952-892-2670 | |
Michele Richardson, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 201 E Nicollet Blvd, Burnsville, MN 55337 Phone: 952-892-2021 Fax: 952-892-2670 | |
Allison Heimer, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 201 E Nicollet Blvd, Fairview Ridges Hospital, Burnsville, MN 55337 Phone: 952-892-2021 Fax: 952-892-2670 | |
Wenlan Cheng, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 201 E Nicollet Blvd, Fv Ridges Hospital, Burnsville, MN 55337 Phone: 952-892-2021 Fax: 952-892-2670 |